Pfizer Inc (PFIZ34) — Cash Flow Quality Index
Pfizer Inc (PFIZ34) has a Cash Flow Quality Index of 0.97x as of March 2026. Operating cash flow of R$2.62 Billion is below net income of R$2.69 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Pfizer Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pfizer Inc Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Pfizer Inc across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pfizer Inc (PFIZ34) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pfizer Inc (2014–2025)
Year-by-year earnings quality comparison for Pfizer Inc. For live market cap and the full company financial profile, see Pfizer Inc (PFIZ34) market capitalisation.
| Year | Quality Index | Operating CF (BRL) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | R$11.71 Billion | R$7.81 Billion | ▼ -5.6% |
| 2024 | 1.59x | R$12.74 Billion | R$8.03 Billion | ▼ -72.1% |
| 2023 | 5.68x | R$12.04 Billion | R$2.12 Billion | ▲ +509.2% |
| 2022 | 0.93x | R$29.27 Billion | R$31.37 Billion | ▼ -37.1% |
| 2021 | 1.48x | R$32.58 Billion | R$21.98 Billion | ▼ -0.7% |
| 2020 | 1.49x | R$14.40 Billion | R$9.65 Billion | ▲ +93.3% |
| 2019 | 0.77x | R$12.59 Billion | R$16.30 Billion | ▼ -45.4% |
| 2018 | 1.41x | R$15.83 Billion | R$11.19 Billion | ▲ +79.8% |
| 2017 | 0.79x | R$16.80 Billion | R$21.36 Billion | ▼ -64.8% |
| 2016 | 2.23x | R$16.19 Billion | R$7.25 Billion | ▲ +5.9% |
| 2015 | 2.11x | R$14.69 Billion | R$6.96 Billion | ▲ +12.8% |
| 2014 | 1.87x | R$17.08 Billion | R$9.13 Billion | — |